# FDA Inspection 1207723 - Beth E. Safirstein, M.D. - June 05, 2023

Source: https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/9900060d-de58-4fd7-9874-2fc71e83b8bc
Source feed: FDA_Inspections

> FDA Inspection 1207723 for Beth E. Safirstein, M.D. on June 05, 2023. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1207723
- Company Name: Beth E. Safirstein, M.D.
- Inspection Date: 2023-06-05
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1207723 - 2023-06-05](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/e0595441-9c6a-4d25-a3f5-654b001a98f8)
- [FDA Inspection 1098747 - 2019-08-06](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/56f744a3-0fd0-4e26-9963-5967f3affe43)
- [FDA Inspection 585191 - 2009-05-22](https://www.keypedia.com/records/fda_inspections/beth-e-safirstein-md/a2bc7837-fa31-463e-8d12-c0e5973192d5)

Company: https://www.keypedia.com/companies/beth-e-safirstein-md/9fdf7e95-e050-4f9d-bcd2-e00665e881c1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d